EMA approves Janssen’s Prezista continuous manufacturing line
The EMA has approved Janssen's continuous manufacturing (CM) with real-time release testing for the production of Prezista (darunavir)...
List view / Grid view
The EMA has approved Janssen's continuous manufacturing (CM) with real-time release testing for the production of Prezista (darunavir)...
SmartAction and EndPoint Technologies have formed a strategic partnership to expand the availability of AI-powered customer technology.
Insurance companies are increasingly embracing innovative mobile solutions with the aim of helping their members live healthier lives and access quality care conveniently and efficiently.
Genpact’s new Pharmacovigilance Artificial Intelligence solution promises to transform drug safety data management and reporting…